Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

showed a trendp = 0.081.6× alpha
The percentage of patients with a survival longer than 12 months only showed a trend, not statistically significant ( p = 0.08), to be higher in the WA group (9 patients, 47%) than the NW group (5 patients, 16%).
showed a trendp=0.081.6× alpha
Mixed results were found on lung function parameters, and a meta-analysis including two studies with comparable methodology showed a trend towards reduced maximum flow rate at functional residual capacity of −34.59 mL/s (95% CI −72.81 to 3.63, p=0.08) in 1-month-old infants born to women who smoked during pregnancy.
showed a trendp = 0.0801.6× alpha
l -Theanine–caffeine combination improved total cognition composite (p = 0.041), d-prime in the Go/NoGo task (p = 0.033) and showed a trend of improvement of inhibitory control (p = 0.080). l -Theanine–caffeine combination was associated with decreased task-related reactivity of a brain network associated with mind wandering (i.e. default mode network). l -Theanine–caffeine combination may be a potential therapeutic option for ADHD-associated impairments in sustained attention, inhibitory control and overall cognitive performance.
showed a trendP = 0.081.6× alpha
Individual housing of mice increases energy expenditure and energy intake and results in anhedonia Indirect calorimetry revealed that energy expenditure was increased in IND compared to SOC: During adolescence (PN40-40), IND showed a trend for higher energy expenditure during the light phase (P = 0.08), this effect reached significance after adjusting for LBM ( Table 3 ).
showed a trendP = 0.081.6× alpha
As shown in Figure 7D , the mean number of action potentials during the 400 ms pulse was substantially higher in this group, and two-way ANOVA showed a trend effect by animal (Ctrl versus Pilo, P = 0.08, indicated by “+,” ANOVA with Tukey post hoc test) and a significant effect by treatment (vehicle versus TBB, P < 0.05, ANOVA with Tukey post hoc test).
showed a trendP =0.081.6× alpha
When changes in postprocedure complications (in‐hospital stroke, blood transfusion, AKI, vascular and respiratory complications) and center volume were accounted for in the model, the RR of 2016 compared with prior years in nonagenarians was attenuated but remained significant (aRR: 0.54; 95% CI, 0.42–0.70; P <0.001 compared with 2012; aRR: 0.80; 95% CI, 0.66–0.96; P =0.02 compared with 2015), whereas high‐volume centers showed a trend with lower 30‐day mortality in the full GEE model (aRR: 0.88; 95% CI, 0.73–1.02; P =0.08).
showed a trendP = 0.081.6× alpha
chemotherapy with adjuvant chemotherapy showed a trend toward improvement in overall survival (HR 0.70; 95% CI 0.47‐1.04; P = 0.08). 61 Ishigami et al. conducted a phase III trial comparing i.p. and i.v. paclitaxel plus S‐1 (IP) versus cisplatin plus S‐1 (SP) in patients with peritoneal metastasis. 62 Although this trial failed to show statistical superiority of intraperitoneal paclitaxel plus systemic chemotherapy, the 3‐year overall survival rate was 21.9% (95% CI, 14.9%‐29.9%) in the IP arm and 6.0% (95% CI, 1.6%‐14.9%) in the SP arm.